In The Global Race
Against Infectious Diseases
Internal Innovation; Active In-Licensing.
Appili Therapeutics is proud to be at the forefront of global efforts to address serious infectious disease threats.
Our systematic approach to building a diverse pipeline provides investment opportunities that serve the needs of patients, payers, and clinicians. Our strategy centers on identifying unmet medical needs, rather than adhering to a specific platform or technology, and matching those needs with potential solutions in the marketplace. This approach provides financial stability and the opportunity to leverage a broad range of government and industry programs, as well as to develop transformative programs that can impact the fundamental treatment landscape for many types of infections.